Latest Articles

  • In reply: The PARADIGM-HF trial (October 2015)
    Marwa A. Sabe, MD, MPH, Miriam S. Jacob, MD and David O. Taylor, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 167-168; DOI: https://doi.org/10.3949/ccjm.83c.03002
  • Advances in the treatment of dyslipidemia
    Marc S. Sabatine, MD, MPH
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 181-186; DOI: https://doi.org/10.3949/ccjm.83gr.16001

    Current guidelines do not set specifi c targets for LDL-C, but evidence supports the concept that lower is better.

  • Celiac disease: Managing a multisystem disorder
    Celiac disease: Managing a multisystem disorder
    Gursimran Singh Kochhar, MD, CNSC, FACP, Tavankit Singh, MD, Anant Gill, MBBS and Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, CNSC, CPNS
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 217-227; DOI: https://doi.org/10.3949/ccjm.83a.14158

    This autoimmune disorder can cause symptoms that involve not only the gastrointestinal tract but also the skin and bones.

  • Can patients with infectious endocarditis be safely anticoagulated?
    Mandeep Singh Randhawa, MD, James Pile, MD and Marcelo Gomes, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 169-171; DOI: https://doi.org/10.3949/ccjm.83a.15027

    New infectious endocarditis is not an indication for starting anticoagulation, and whether to continue it is a diffi cult decision.

  • Blood pressure management in the wake of SPRINT
    Edward J. Filippone, MD, FACP and Andrew J. Foy, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 196-198; DOI: https://doi.org/10.3949/ccjm.83a.16015

    SPRINT should be interpreted in the context of prior trials and of its inclusion and exclusion criteria.

  • Fungal folliculitis masquerading as acute exanthematous pustulosis
    Timmie Sharma, MD, Alok Vij, MD and Apra Sood, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 179-180; DOI: https://doi.org/10.3949/ccjm.83a.15028

    Concern was raised for antibiotic-related acute exanthematous pustulosis, but punch biopsy revealed the yeast Malassezia.

  • The PARADIGM-HF trial (October 2015)
    Robert P. Blankfield, MD, MS
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 167; DOI: https://doi.org/10.3949/ccjm.83c.03001

    A reader comments on the fi ndings of the PARADIGM-HF trial (October 2015).

  • Prescribing opioids in primary care: Safely starting, monitoring, and stopping
    Daniel G. Tobin, MD, FACP, Rebecca Andrews, MD, FACP and William C. Becker, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 207-215; DOI: https://doi.org/10.3949/ccjm.83a.15034

    Prescription drug abuse has reached epidemic proportions. Some patients benefi t from opioids, but many suffer harm.

  • The emotional impact of a malpractice suit on physicians: Maintaining resilience
    Susan J. Rehm, MD and Bradford L. Borden, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 177-178; DOI: https://doi.org/10.3949/ccjm.83a.16004

    Resilient people can face reality, see a better future, put things into perspective, and bounce back from adversity.

  • When we need to remember that it is more than a job
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 159-166; DOI: https://doi.org/10.3949/ccjm.83b.03016

    It is the nature of our engagement with our patients and our colleagues that makes what we do more than a job.

Pages